Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in the Italian Clinical Practice: a Retrospective Cohort, Observational Study

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2019

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

06 Nov 2019 Results of cost sub analysis aimed to estimate the health care costs related to schizophrenia in patients who had started aripiprazole long-acting injectable (LAI) treatment in the DOMINO study, presented at the 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
14 Jul 2017 Status changed from recruiting to completed.
03 Jan 2017 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com